Capecitabine containing-regimen
Combination chemotherapy with platinum salts
Ixabepilone based chemotherapy
Nontaxane microtubule dynamics inhibitor
Vinorelbine containing regimen
Selective estrogen receptor modulator (SERM)
Selective estrogen receptor downregulators (SERDs)
Locoregional treatment of the primary tumor
CDK (cyclin-dependent kinase) inhibitor
Histone deacetylase (HDAC) inhibitors
Phosphoinositide 3-kinase inhibitor
Poly ADP-ribose polymerase (PARP) inhibitor
Active compression-decompression CPR
Agents to slow down human AAA-expansion
Bioresorbable vascular scaffold
Endothelin receptor antagonist
Increasing hemoglobin concentration
Increasing hemoglobin concentration
Modified resuscitation protocol
Phosphodiesterase III inhibitors
Plasma homocysteine lowering intervention
Primary prevention of sudden death
Transcatheter aortic-valve implantation (TAVI)
Transmyocardial revacularization
Intensive blood pressure control
Angiotensin renin system blockade
Angiotensin-Converting Enzyme Inhibitors
Combined inhibition of ACE and neprilysin
Inhibition of the renin-angiotensin system (ACEI or ARB)
Antidiabetic drugs added to metformin
Glucose lowering for cardiovascular prevention
Insulin secretagogues - DPP-4 inhibitors
Insulin secretagogues - Meglitinides (glinides)
Insulin secretagogues - sulfonylureas
Insulin secretagogues peptides (incretins)
Insulin sensitizer - biguanides
Insulin sensitizers - glitazones
Insulin sensitizers - PPAR modulator
Direct oral anticoagulant (DAO)
Cholesterol lowering intervention
Catheter ablation of ventricular tachycardia
Graduated compression stockings
Mechanical devices for thromboprophylaxis
Percutaneous left ventricular assist device
Percutaneous left ventricular assist devices
Resynchronization (CRT) - defibrillators (ICD)
Mineralocorticoid receptor antagonists
Fractional-flow-reserve-guided PCI